Replies to post #29 on Ampio Pharmaceuticals Inc (AMPE)

[surf1944]

7:02AM Ampio Pharma announces statistically significant improvement in pain relief for Ampion in the osteoarthritis of the knee trial (AMPE) 4.08 : Co announced preliminary results of the pain score portion of the expansion phase of Ampion in Knee trial which was recently completed in Australia. Preliminary analysis of the pain scores portion of the trial demonstrated positive results, suggesting that Ampion may be a therapeutic alternative to steroids for osteoarthritis with a 'very favorable' safety profile.